DePuy Orthopaedics, Inc. and the Court-appointed committee of lawyers representing ASR Hip System plaintiffs have announced two settlement agreements to compensate eligible ASR patients in the United States who had surgery to replace their ASR hip, known as revision surgery. The 2013 settlement agreement compensates eligible ASR patients in the United States who had revision surgery as of August 31, 2013. The 2015 settlement agreement compensates eligible ASR patients in the United States who had revision surgery after August 31, 2013, and on or before January 31, 2015. For more information on the U.S. settlement program, please (click here).
The settlement agreements will help bring to a close significant ASR litigation activity in the U.S. However, some lawsuits in the U.S. will remain. DePuy will continue to defend against remaining claims and believes its actions related to the ASR Hip System have been appropriate and responsible.
Three ASR Hip System cases have gone to trial in the United States. A trial in the Tulsa County District Court, Civil Division, that ended in February 2015, resulted in a mixed verdict, and the company plans to appeal the jury’s verdict regarding design defect. In a trial in the Circuit Court of Cook County, Illinois, that ended in April 2013, the jury returned a verdict in favor of DePuy Orthopaedics, Inc. A trial in the California Superior Court, Los Angeles County, that ended in March 2013, resulted in a mixed verdict, and the company has appealed the jury's verdict regarding design defect.
Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Ohio (click here for website). Litigation has also been filed in countries outside of the United States.
As of January 3, 2016, in the U.S. there were approximately 5,300 plaintiffs with direct claims in pending lawsuits with respect to the ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System.